CENTESSA PHARMACEUTICALS (UK) LIMITED
Company number 13040752
- Company Overview for CENTESSA PHARMACEUTICALS (UK) LIMITED (13040752)
- Filing history for CENTESSA PHARMACEUTICALS (UK) LIMITED (13040752)
- People for CENTESSA PHARMACEUTICALS (UK) LIMITED (13040752)
- Charges for CENTESSA PHARMACEUTICALS (UK) LIMITED (13040752)
- More for CENTESSA PHARMACEUTICALS (UK) LIMITED (13040752)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
26 Apr 2021 | PSC05 | Change of details for United Medicines Biopharma Limited as a person with significant control on 17 February 2021 | |
23 Apr 2021 | AA01 | Current accounting period extended from 30 November 2021 to 31 December 2021 | |
20 Apr 2021 | TM02 | Termination of appointment of Nicholas Alexander James Tait as a secretary on 20 April 2021 | |
22 Feb 2021 | TM01 | Termination of appointment of Richard Michael Lee as a director on 19 February 2021 | |
22 Feb 2021 | AP01 |
Appointment of Ms Marella Thorell as a director on 19 February 2021
|
|
22 Feb 2021 | AP01 | Appointment of Mr Iqbal Hussain as a director on 19 February 2021 | |
22 Feb 2021 | AP01 | Appointment of Dr Saurabh Saha as a director on 19 February 2021 | |
22 Feb 2021 | TM01 | Termination of appointment of Francesco De Rubertis as a director on 19 February 2021 | |
17 Feb 2021 | RESOLUTIONS |
Resolutions
|
|
11 Dec 2020 | AP03 | Appointment of Mr Nicholas Alexander James Tait as a secretary on 24 November 2020 | |
07 Dec 2020 | AP01 | Appointment of Mr Francesco De Rubertis as a director on 4 December 2020 | |
24 Nov 2020 | NEWINC |
Incorporation
Statement of capital on 2020-11-24
|